Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 700 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ALX Oncology Holdings Inc.
Market Cap
$155.61M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$153.89M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-6695.15%
Market Cap
$159.80M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.79%
Market Cap
$152.69M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$152.20M
Net Profit Margin
-39.55%
TTM Avg
-86.23%
3Y Avg
-76.35%
5Y Avg
-60.08%
Market Cap
$158.79M
Net Profit Margin
-6.94%
TTM Avg
-8.61%
3Y Avg
-17.97%
5Y Avg
-12.59%
Market Cap
$155.86M
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$149.87M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-85.02%
Market Cap
$148.77M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc. (ALXO) | $155.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $153.89M | 0.00% | 0.00% | 0.00% | -6695.15% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | 0.00% | 0.00% | 0.00% | 0.79% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Codexis, Inc. (CDXS)vs › | $152.20M | -39.55% | -86.23% | -76.35% | -60.08% |
| Inogen, Inc. (INGN)vs › | $158.79M | -6.94% | -8.61% | -17.97% | -12.59% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | 0.00% | 0.00% | 0.00% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.87M | 0.00% | 0.00% | 0.00% | -85.02% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -10.40% | -6.28% | -16.07% | -47.85% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | -2150.09% |
| 2020-03-31 | -832.67% |
| 2019-12-31 | -640.07% |
| 2019-09-30 | -242.36% |
| 2019-06-30 | -324.09% |
| 2019-03-31 | -410.66% |
